Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vaginal epithelial surface and local microbiota niche constitute a specialized microenvironment critical for maintaining reproductive health and preventing infection (Amabebe & Anumba, 2018, Front Med). The non-keratinized stratified squamous epithelium serves as a physical barrier and an active immunological site, while the resident microbiota—predominantly Lactobacillus species—maintains a low pH (typically <4.5) through the fermentation of glycogen-derived products into lactic acid (Ravel et al., 2011, PNAS; O'Hanlon et al., 2013, PLoS ONE). This acidic environment, supplemented by the secretion of antimicrobial peptides and hydrogen peroxide, provides a robust defense against urogenital pathogens and sexually transmitted infections (STIs). Dysbiosis within this niche, such as the depletion of lactobacilli and overgrowth of anaerobes seen in bacterial vaginosis, is associated with increased risks of HIV acquisition, pelvic inflammatory disease, and preterm birth (Coudray & Madhivanan, 2020, BMC Womens Health). Pharmacological and biotherapeutic strategies targeting this niche, such as the use of live biotherapeutic products like Lactin-V, aim to eradicate pathogens, restore the protective microbial flora, or reinforce the epithelial barrier to maintain local homeostasis (Cohen et al., 2020, NEJM).
Restoration of microbial homeostasis, acidification of the vaginal environment, and competitive exclusion of pathogens (Cohen et al., 2020, NEJM; O'Hanlon et al., 2013, PLoS ONE).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal epithelial surface and local microbiota niche.